Resource library

Videos

See all videos

Brochures

Tumor Assessment Using RECIST 1.1 and mRECIST: Quick Reference Sheet

See all brochures

White papers

Understanding Novel Response Patterns of Immunotherapies

Immunotherapies display novel response patterns that affect the design of imaging based studies and the subsequent evaluation of imaging data. Applying traditional chemotherapy-based response assumptions to immunotherapy trials can result in inaccurate interpretation of response, premature therapy termination, and unnecessary removal of subjects from a trial. Our unique solutions for medical image analysis and management and iBiopsy® for imaging phenotyping, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy.

See all white papers

Case studies

Accelerated turnaround time for confirmation of progressive disease

See all case studies

Scientific publications

Imaging biomarker phenotyping system (iBiopsy) to accelerate hepatocellular carcinoma (HCC) drug development

Yan Liu [1], Corinne Ramos [1], Pierre Baudot [1], Johan Brag [1], Olivier Lucidarme [2] - Affiliations: [1] Median Technologies, Valbonne, France. [2] Radiology Unit, Pitié Salpétrière Hospital, APHP, Paris, France.

Current drug therapies in HCC remain limited because of substantial genomic, cellular and molecular heterogeneity of the liver tumor microenvironment (TME). This heterogeneity has implications for tumor development, immune response and cellular invasion and is compounded by multiple molecular pathways related to the various HCC etiologies. In this context, it is challenging to find biomarkers that are predictive of therapeutic response or outcome. A systems biology approach leveraging the iBiopsy phenotyping platform to automatically detect HCC and TME subtypes using non-invasive medical imaging could help identify specific disease pathways and accelerate HCC drug development.

See publication
See all scientific publications

Cookies help us deliver our services. By using our services, you agree to our use of cookies.